FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056558450> ?p ?o ?g. }

• W2056558450 endingPage "281" @default.
• W2056558450 startingPage "275" @default.
• W2056558450 abstract "Objective: To investigate the potential of gadofosveset-enhanced MR imaging for the characterization of human carotid atherosclerotic plaques. Materials and Methods: Sixteen (9 symptomatic, 7 asymptomatic) patients with 70% to 99% carotid stenosis (according to NASCET criteria) were included (13 men, 3 women, mean age 67.6 years). All patients underwent baseline precontrast MR imaging of the carotid plaque. Immediately after completion of the baseline examination, 0.03 mmol/kg gadofosveset was administered. At 24 hours postinjection, the acquisition was repeated. Twelve patients were scheduled for carotid endarterectomy. Carotid endarterectomy specimens were HE-, CD31-, CD68-, and albumin-stained to correlate signal enhancement with plaque composition, intraplaque microvessel density, and macrophage and albumin content. A random intercept model was used to compare signal enhancement between symptomatic and asymptomatic patients, adjusting for size of various plaque components. This study was approved by the institutional medical ethics committee. All participants gave written informed consent. Results: Signal enhancement (SE) of the plaque was significantly higher in symptomatic patients compared with asymptomatic patients (median log SE 0.182 vs. −0.109, respectively, P < 0.001). A positive association (as expressed by a regression coefficient β = 0.0035) was found between signal enhancement on the log scale and intraplaque albumin content (P = 0.038). There was no association between signal enhancement and various other plaque components. Conclusion: In this study, the potential of gadofosveset-enhanced human carotid plaque MR imaging for identification of high-risk plaques was demonstrated. Signal enhancement of the plaque after administration of gadofosveset was associated with differences in intraplaque albumin content. Although promising, we emphasize that these results are based on a small patient population. Larger prospective studies are warranted." @default.
• W2056558450 created "2016-06-24" @default.
• W2056558450 creator A5009602483 @default.
• W2056558450 creator A5017817427 @default.
• W2056558450 creator A5022556494 @default.
• W2056558450 creator A5026288023 @default.
• W2056558450 creator A5047399327 @default.
• W2056558450 creator A5050858083 @default.
• W2056558450 creator A5053071529 @default.
• W2056558450 creator A5053337121 @default.
• W2056558450 creator A5063840601 @default.
• W2056558450 creator A5067700465 @default.
• W2056558450 creator A5069732992 @default.
• W2056558450 creator A5080879063 @default.
• W2056558450 creator A5082981433 @default.
• W2056558450 date "2010-05-01" @default.
• W2056558450 modified "2023-09-27" @default.
• W2056558450 title "Gadofosveset-Enhanced Magnetic Resonance Imaging of Human Carotid Atherosclerotic Plaques" @default.
• W2056558450 cites W1602214891 @default.
• W2056558450 cites W1974703303 @default.
• W2056558450 cites W1987335375 @default.
• W2056558450 cites W1989511609 @default.
• W2056558450 cites W1997410071 @default.
• W2056558450 cites W2012033295 @default.
• W2056558450 cites W2030777991 @default.
• W2056558450 cites W2036261957 @default.
• W2056558450 cites W2061896040 @default.
• W2056558450 cites W2064582130 @default.
• W2056558450 cites W2071495935 @default.
• W2056558450 cites W2081985315 @default.
• W2056558450 cites W2082382887 @default.
• W2056558450 cites W2084710341 @default.
• W2056558450 cites W2097631243 @default.
• W2056558450 cites W2100340069 @default.
• W2056558450 cites W2113809297 @default.
• W2056558450 cites W2133605366 @default.
• W2056558450 cites W2133858220 @default.
• W2056558450 cites W2137892592 @default.
• W2056558450 cites W2143032925 @default.
• W2056558450 cites W2151483994 @default.
• W2056558450 cites W2153132720 @default.
• W2056558450 cites W2156678187 @default.
• W2056558450 cites W2161682643 @default.
• W2056558450 cites W2167088056 @default.
• W2056558450 cites W4256475235 @default.
• W2056558450 doi "https://doi.org/10.1097/rli.0b013e3181d5466b" @default.
• W2056558450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20351652" @default.
• W2056558450 hasPublicationYear "2010" @default.
• W2056558450 type Work @default.
• W2056558450 sameAs 2056558450 @default.
• W2056558450 citedByCount "47" @default.
• W2056558450 countsByYear W20565584502012 @default.
• W2056558450 countsByYear W20565584502013 @default.
• W2056558450 countsByYear W20565584502014 @default.
• W2056558450 countsByYear W20565584502015 @default.
• W2056558450 countsByYear W20565584502016 @default.
• W2056558450 countsByYear W20565584502017 @default.
• W2056558450 countsByYear W20565584502018 @default.
• W2056558450 countsByYear W20565584502019 @default.
• W2056558450 countsByYear W20565584502020 @default.
• W2056558450 countsByYear W20565584502021 @default.
• W2056558450 countsByYear W20565584502022 @default.
• W2056558450 crossrefType "journal-article" @default.
• W2056558450 hasAuthorship W2056558450A5009602483 @default.
• W2056558450 hasAuthorship W2056558450A5017817427 @default.
• W2056558450 hasAuthorship W2056558450A5022556494 @default.
• W2056558450 hasAuthorship W2056558450A5026288023 @default.
• W2056558450 hasAuthorship W2056558450A5047399327 @default.
• W2056558450 hasAuthorship W2056558450A5050858083 @default.
• W2056558450 hasAuthorship W2056558450A5053071529 @default.
• W2056558450 hasAuthorship W2056558450A5053337121 @default.
• W2056558450 hasAuthorship W2056558450A5063840601 @default.
• W2056558450 hasAuthorship W2056558450A5067700465 @default.
• W2056558450 hasAuthorship W2056558450A5069732992 @default.
• W2056558450 hasAuthorship W2056558450A5080879063 @default.
• W2056558450 hasAuthorship W2056558450A5082981433 @default.
• W2056558450 hasConcept C126838900 @default.
• W2056558450 hasConcept C142724271 @default.
• W2056558450 hasConcept C143409427 @default.
• W2056558450 hasConcept C2777910003 @default.
• W2056558450 hasConcept C2780007028 @default.
• W2056558450 hasConcept C2781068581 @default.
• W2056558450 hasConcept C2989005 @default.
• W2056558450 hasConcept C71924100 @default.
• W2056558450 hasConceptScore W2056558450C126838900 @default.
• W2056558450 hasConceptScore W2056558450C142724271 @default.
• W2056558450 hasConceptScore W2056558450C143409427 @default.
• W2056558450 hasConceptScore W2056558450C2777910003 @default.
• W2056558450 hasConceptScore W2056558450C2780007028 @default.
• W2056558450 hasConceptScore W2056558450C2781068581 @default.
• W2056558450 hasConceptScore W2056558450C2989005 @default.
• W2056558450 hasConceptScore W2056558450C71924100 @default.
• W2056558450 hasIssue "5" @default.
• W2056558450 hasLocation W20565584501 @default.
• W2056558450 hasLocation W20565584502 @default.
• W2056558450 hasOpenAccess W2056558450 @default.
• W2056558450 hasPrimaryLocation W20565584501 @default.
• W2056558450 hasRelatedWork W1545803792 @default.

• next